Rambo Medical Group Inc. (RMGI) Financials Nov 11,
Post# of 250675
Posted On: 11/17/2014 4:46:12 AM
Rambo Medical Group Inc. (RMGI) Financials Nov 11, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Rambo Medical Group Inc.
Fiscal year is June-May. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 434 870 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 434 870 0 0 0
Depreciation 434 870 - 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income (434) (870) 0 0 0
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 281,464 376,522 363,227 38,090 41,610
Research & Development 0 0 0 - -
Other SG&A 281,464 376,522 363,227 38,090 41,610
Other Operating Expense 276,156 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense (5.23M) (1,592) 1,509 0 0
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 6,659 0 0 0 0
Gross Interest Expense 6,659 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income (5.8M) (378,984) (361,718) (38,090) (41,610)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (5.8M) (378,984) (361,718) (38,090) (41,610)
Minority Interest Expense 0 0 0 0 0
Net Income (5.8M) (378,984) (361,718) (38,090) (41,610)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (5.8M) (378,984) (361,718) (38,090) (41,610)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (5.8M) (378,984) (361,718) (38,090) (41,610)
EPS (Basic) (8.00) () () (4.00) (0.04)
Basic Shares Outstanding 759,602 834,332 854,277 9,912 992,192
EPS (Diluted) (8.00) () () (4.00) (0.04)
Diluted Shares Outstanding 759,602 834,332 854,277 9,912 992,192
EBITDA (557,620) (376,522) (363,227) (38,090) (41,610)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Rambo Medical Group Inc.
Fiscal year is June-May. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 434 870 0 0 0
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 434 870 0 0 0
Depreciation 434 870 - 0 0
Amortization of Intangibles 0 0 0 0 0
Gross Income (434) (870) 0 0 0
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 281,464 376,522 363,227 38,090 41,610
Research & Development 0 0 0 - -
Other SG&A 281,464 376,522 363,227 38,090 41,610
Other Operating Expense 276,156 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense (5.23M) (1,592) 1,509 0 0
Non-Operating Interest Income 0 0 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 6,659 0 0 0 0
Gross Interest Expense 6,659 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income (5.8M) (378,984) (361,718) (38,090) (41,610)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (5.8M) (378,984) (361,718) (38,090) (41,610)
Minority Interest Expense 0 0 0 0 0
Net Income (5.8M) (378,984) (361,718) (38,090) (41,610)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (5.8M) (378,984) (361,718) (38,090) (41,610)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (5.8M) (378,984) (361,718) (38,090) (41,610)
EPS (Basic) (8.00) () () (4.00) (0.04)
Basic Shares Outstanding 759,602 834,332 854,277 9,912 992,192
EPS (Diluted) (8.00) () () (4.00) (0.04)
Diluted Shares Outstanding 759,602 834,332 854,277 9,912 992,192
EBITDA (557,620) (376,522) (363,227) (38,090) (41,610)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)